Kristin Ladell

Clinical Reader & Doctor in Paediatrics

Cardiff University

United Kingdom

Research Interests

Explore related searches

Professors in United Kingdom Professors in Immunology Immunology professors in United Kingdom

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Kristin Ladell is a Clinical Reader and Doctor in Paediatrics at Cardiff University, UK. Her research encompasses various areas including long COVID biomarkers, immune responses to Group A Streptococcus , and T cell receptor specificity in relation to viral infections. Recent publications highlight her work on immune activation mechanisms and the effects of SARS-CoV-2 on innate immunity.

Articles (11)

Year:

2025

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Collaborators (15)

Louise Rowntree

University of Melbourne

AUSTRALIA

Kristin Ladell

Research Interests

Explore related searches

Contact this professor

About

Articles (11)

Identification of soluble biomarkers that associate with distinct manifestations of long COVID

The superantigens SpeC and TSST-1 specifically activate TRBV12-3/12-4+ memory T cells

Group A <i>Streptococcus</i> induces CD1a-autoreactive T cells and promotes psoriatic inflammation.

CD4<sup>+</sup> T cell-mediated recognition of a conserved cholesterol-dependent cytolysin epitope generates broad antibacterial immunity.

VDJdb in the pandemic era: a compendium of T cell receptors specific for SARS-CoV-2

SARS-CoV-2 host-shutoff impacts innate NK cell functions, but antibody-dependent NK activity is strongly activated through non-spike antibodies

Epitope length variants balance protective immune responses and viral escape in HIV-1 infection.

Preexisting memory CD4+ T cells contribute to the primary response in an HIV-1 vaccine trial

CD8 coreceptor-mediated focusing can reorder the agonist hierarchy of peptide ligands recognized via the T cell receptor

Synthetic Peptides with Inadvertent Chemical Modifications Can Activate Potentially Autoreactive T Cells.

Monoclonal antibodies targeting nonstructural viral antigens can activate ADCC against human cytomegalovirus

Collaborators (15)

Louise Rowntree

James McLaren

Victor Appay

Stephen Man

Eddie Wang

Ian Humphreys

James Redman

Sarah Adamo

Matthias Eberl

Kristen W Cohen

Peter van Endert

Yi-Ling Chen

Paul Goepfert

David Andrew Duncan

David Price

Make your next move.